The Chittaranjan National Cancer Institute (CNCI), Kolkata, has announced a golden opportunity for qualified candidates to join its esteemed institution as a Senior Resident in the Department of Radiation Oncology. The recruitment is on a 44-day basis, with potential for extension based on performance and conduct.
This article provides all the essential details regarding the recruitment process, eligibility criteria, and application procedure.
Overview of CNCI Kolkata Recruitment 2024
- Position: Senior Resident
- Department: Radiation Oncology
- Vacancies: 01
- Pay: ₹1,32,660 (inclusive of all allowances)
- Tenure: 44 days (extendable based on performance and conduct)
- Age Limit: Maximum 37 years (relaxable as per Government of India rules)
Eligibility Criteria
Candidates must fulfill the following requirements to apply:
Educational Qualification
- A recognized medical qualification listed in the Indian Medical Council Act, 1956.
- Postgraduate degree in Radiation Oncology from a recognized university.
- Must possess a valid MCI Registration Certificate.
Experience
- Preference will be given to candidates with prior experience in the Radiation Oncology department.
Age Limit
- The maximum age limit is 37 years, with relaxations for reserved categories as per government norms.
Application Process
Interested candidates must follow these steps to apply:
Application Fee
- ₹200, payable via:
- Demand Draft: Drawn in favor of “Director, CNCI, Kolkata,” payable at SBI, Bhowanipore Branch, Kolkata (IFSC Code: SBIN0000040).
- Bank Transfer: Account No. 11126767907, SBI Bhowanipore Branch, IFSC Code: SBIN0000040.
Walk-In-Interview
- Date: 8th January 2025
- Time: From 11:00 AM
- Venue: O.I.C(H) Office, CNCI 1st Campus (Hazra), Kolkata.
Documents to Bring
- Duly completed application form.
- Original and self-attested copies of relevant documents, including educational certificates and ID proof.
- Demand Draft or proof of bank transfer for the application fee.
Important Dates
- Notification Released: 19th December 2024
- Walk-In-Interview: 8th January 2025